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Growing single crystals of small molecules by
thermal recrystallization, a viable option even for
minute amounts of material?†
Philipp P. Nievergelt and Bernhard Spingler*
The growth of single crystals of small molecules by thermal recrystallization of only a few milligrams of
material has been studied for carbamazepine, para-aminobenzoic acid and vitamin B12. High quality single
crystals could be grown for carbamazepine and para-aminobenzoic acid within just six hours. Various sol-
vents and concentrations were tested for their influence upon the growth of crystals.
1. Introduction
In contrast to inorganic polymeric materials, for which single
crystals are frequently grown by thermal recrystallization,1,2
thermal recrystallization of small molecules is described in
most introductions into single crystal growth,3 however the
method is rarely used in research laboratories.4–8 There is an
exceptional report about the extremely slow cooling of an eth-
anol solution (0.5 °C per day) to achieve growth of a single
crystal of an organic compound.9 Another report described a
single crystal grown by cooling a 150 °C hot solution at a rate
of −1.25 °C per hour.10 In many cases, it is essential that the
employed crystallization methods only use few milligrams of
material, as the supply of the compound of interest is
limited.11
In this publication, we describe our results from attempts
to grow single crystals of 3 different molecular compounds
(carbamazepine, para-aminobenzoic acid and vitamin B12) by
thermal recrystallization using a small volume of only 0.1 ml
with the help of the CrystalBreeder. The single crystals had to
have sufficient quality and size in order to allow X-ray analy-
sis on a source diffractometer equipped with a CCD detector
and Microfocus Mo and Cu X-ray tubes respectively. This
publication is meant to be an extension of our previous tuto-
rial about the growth of single crystals of small molecules,
which focused on isothermal methods.11
2. Experimental section
Carbamazepine (CBZ, 97%, P-monoclinic form III,12 see ESI;†
we employ the nomenclature of ref. 13) was purchased from
ABCR GmbH & Co. KG. Para-Aminobenzoic acid (pABA,
≥99%, α-form, see ESI†14), 1-propanol (≥99%), 2-propanol
(≥99.5%), 2-butanol (≥99%), tetrahydrofuran (THF, ≥99.9%),
cyclohexane (≥99.5%), acetonitrile (≥99.9%) and ethyl ace-
tate (≥99.9%) were purchased from Sigma Aldrich. All
chemicals were used without further purification.
The crystallization experiments were performed with help
of the CrystalBreeder (CB), a multi-reactor crystallization plat-
form for medium-throughput solid state research. The CB
shows real time turbidity information for 32 parallel vials
with a working volume of only 0.1 ml. The vials are arranged
in 8 blocks, which can be temperature controlled indepen-
dently within a range of −15 °C to 145 °C.
UPLC-ESI-MS spectra were recorded on an Acquity Waters
system equipped with a PDA detector and an autosampler
using an ACQUITY UPLC BEH C18 Gravity 1.7 μm (2.1 mm ×
50 mm) reverse phase column. The UPLC system was
connected to a Bruker Daltonics HCT ESI-MS spectrometer. A
total volume of 1 μL of a sample solution was analysed. A gra-
dient (0 to 0.5 min 5% B, 0.5 to 2 min 30% B, 2 to 4 min
100% B, 4 to 5 min 100% B) of acetontitrile (solvent B) versus
Millipore water containing 0.1% formic acid (solvent A) was
applied using a flow rate of 0.3 ml min−1. All solvents used
were of LCMS grade.
2.1 Thermal crystallization of carbamazepine
The carbamazepine single crystals were grown by thermal
crystallization in various solvents and with various concentra-
tions always with 0.1 ml of solvent (Table 1).
For every solvent, a minimum of four different concentra-
tions were chosen. Each sample was heated at 1 °C min−1
starting from room temperature until five degrees below the
142 | CrystEngComm, 2017, 19, 142–147 This journal is © The Royal Society of Chemistry 2017
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boiling point of the solvent, held at this temperature for 15
minutes, cooled at −0.5 °C min−1 until −15 °C (for cyclohex-
ane only until 0 °C because its melting point is at 7 °C and
the solution should not be frozen) and held at the lowest
temperature for 15 minutes (Table 2). All samples were
stirred with a paddle while heating to ensure that all solids
had dissolved. The stirrers were turned off during the
cooling.
2.2 Thermal crystallization of p-aminobenzoic acid (pABA)
Crystals of para-aminobenzoic acid were grown by the same
method used for CBZ (Tables 3 and 4).
2.3 Thermal crystallization of vitamin B12
Crystals of vitamin B12 were grown by the same method used
for CBZ. The reported solubility of vitamin B12 in water is
10.2 g l−1,18 however we employed higher concentrations of 4
to 8 mg of vitamin B12 in 0.1 ml of water. We obtained crys-
tals by cooling down from 95 °C to −5 °C with cooling rates
of either −0.1 or −0.05 °C min−1. Unfortunately, in both cases,
the obtained crystal quality was not good enough for an X-ray
analysis, since the crystals were clearly not single (see Fig. S1
in the ESI†). Using smaller crystals did not help, as it is our
repeated experience with crystals derived from B12 that they
need a much bigger size to diffract decently compared with
“normal” small molecules.19–26 Furthermore, we have previ-
ously made the experience that vitamin B12 and its derivates
are rather delicate molecules to crystallize, that only appreci-
ate very few crystallization conditions. Using a concentration
of 20 g l−1 (twice the reported concentration of saturation)
did not yield any B12 crystals. We checked by UPLC-ESI-MS
whether any degradation like hydrolysis of the amide group
or removal of the cyanide of the B12 was observed during the
extended thermal treatment in an aqueous solution. As can
be seen in Fig. S2 in the ESI,† no deterioration of the B12
could be observed, when compared with B12 that did not un-
dergo any thermal treatment, based upon peak purity, reten-
tion time and isotopic distribution of the mass spectra.
2.4 X-ray measurement
Crystallographic data were collected at 183(2) K on an Agilent
SuperNova, dual source, single X-ray diffractometer equipped
with an Atlas CCD detector with either Mo Kα radiation (λ =
0.7107 Å) for the monoclinic form of CBZ and pABA or with
Cu Kα radiation (λ = 1.54184 Å) for the rhombohedral form
of CBZ. Suitable crystals were covered with oil (Infineum
V8512, formerly known as Paratone N), placed on a nylon
loop that is mounted on a CrystalCap Magnetic™ (Hampton
Research) and immediately transferred to the diffractometer.
Data were corrected for Lorentz and polarisation effects as
well as for absorption. The program suite CrysAlisPro was
used for data collection, multi-scan absorption correction
(additionally a numerical absorption correction was done for
pABA) and data reduction.27 Structures were solved with di-
rect methods using SIR97 (ref. 28) and were refined by full-
matrix least-squares methods on F2 with SHELXL-2014.29
CCDC-1494536–1494538 contain the supplementary crystallo-
graphic data for this paper.
3. Results and discussion
For every solvent at least four different concentrations were
chosen. The lowest concentration was at about 75% of the
solubility at room temperature and the other three concentra-
tions were from 100 to 150/200% of the RT solubility. Each
sample was heated until five degrees below the boiling point
of the solvent. Despite the small starting volume, no solvent
loss from tube could be observed. However, in case of viscous
solvents (like water), up to 18% of the solvent ended up in
Table 1 Properties of solvents tested for the thermal recrystallization of CBZ
Solvent Solubility of CBZ in that solvent Melting point Boiling point
Mass (in mg) of CBZ for 0.1 ml
of a saturated solution
1-Propanol 18.1 g l−1 (25 °C)15 −126 °C 97 °C 1.8
2-Propanol 9.11 g l−1 (25 °C)15 −88 °C 82 °C 0.91
2-Butanol ∼8 g l−1 (25 °C)a −115 °C 99 °C 0.8
THF 45.2 g l−1 (22.4 °C)16 −108 °C 66 °C 4.5
Cyclohexane 0.055 g l−1 (25 °C)15 6.7 °C 81 °C 0.005
a Estimated from the solubility in 2-propanol.
Table 2 Chosen amounts of CBZ and thermal recrystallization cycle
Solvent
Vial 1
(mg)
Vial 2
(mg)
Vial 3
(mg)
Vial 4
(mg)
Heating rate
(°C min−1)
Max temp.
(°C)
Cooling rate
(°C min−1)
Lowest temp.
(°C)
1-Propanol 1.5 2 2.5 3 1 92 0.5 −15
2-Propanol 0.5 1 1.5 2 1 77 0.5 −15
2-Butanol 0.5 1 1.5 2 1 94 0.5 −15
THF low conc. 4.5 5 5.5 6 1 60 0.5 −15
THF high conc. 6 6.5 7 7.5 1 60 0.5 −15
Cyclohexane 0.005 0.01 0.02 0.05 1 76 0.5 0
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separated drops above the original solution between the
outer wall and the paddle.
3.1 Carbamazepine crystals
Carbamazepine is known to form five polymorphs and many
solvates.13,30 While there are many publications about the in-
fluence of cooling rates, concentrations, solvents, seeds and
stirring rates upon the (co)formation of one of these
polymorphs,5,13,15,16,30–36 the focus of this work is exclusively
on the formation of single crystals suitable for X-ray analysis.
We have tested five different solvents at 4–8 concentrations
for the growth of carbemazepine single crystals upon cooling
back to the originally (super)saturated solutions at room tem-
perature. No crystals or even any precipitate could be
obtained from 1-propanol. In the case of 2-propanol,
colourless, thin needles and prismatic single crystals
appeared on the bottom of the vials with 1.5 mg and 2 mg of
material (Fig. 1), respectively. Only one small crystal grew on
the pedal stirrer in the vial with 1 mg of CBZ. By single-
crystal analysis, we could show that the needles are the CBZ
P-monoclinic form III and that the thick, prismatic,
3-dimensional crystals are CBZ with one sixth occupied water
molecule as a solvate crystallizing in the space group R3¯
(Fig. 3 left and Table 5). It must be noted that in several pub-
lications, an identical rhombohedral cell has been reported,
however once the single crystal data were refined without any
solvate molecules and named trigonal form II.37 In two other
publications with a very similar cell, one partially occupied
THF38 or a partially occupied water35 were found in the struc-
ture. As in 2-propanol, needle-shaped crystals of CBZ grew
from 2-butanol on the bottom of the vial and on the stirrer.
However, no prismatic single crystals appeared. From THF,
CBZ crystallized not only as needles but also as prismatic sin-
gle crystals (Fig. 2). At a concentration of 50 mg ml−1, needle-
like crystals appeared on the bottom of the vial and on the
stirrer (Fig. 2 left). Increasing the concentration to 55 mg
ml−1 yielded crystalline needles in the vial and one small pris-
matic crystal on the edge of the vial (Fig. 2 middle). Finally,
just one large single crystal can be seen in the vial with a con-
centration of 60 mg ml−1 (Fig. 2 right). Only a few small, crys-
talline needles grew on the stirrer from cyclohexane, as was
expected due to the low solubility of CBZ in cyclohexane.
Matzger and co-workers obtained the P-monoclinic form
III by slow evaporation from ethanol and the metastable tri-
gonal form II by cooling a hot ethanol solution.13 Both forms
were characterized by X-ray powder diffraction. Sefcik ob-
served a temporary formation of form II in ethanol followed
by appearance of form III.34 They noted the influence of stir-
ring and of an unknown impurity upon the crystallization
pathway.
3.2 p-Aminobenzoic acid crystals
pABA did not form any crystals in 2-propanol for all concen-
trations used in the experiments. In ethyl acetate, plate-like
crystals of pABA formed (Fig. 4). In acetonitrile, the same re-
sult was obtained as in ethyl acetate: some needle crystals
were formed on the bottom of the vial. Single crystals of ex-
cellent quality were obtained from ethyl acetate at concentra-
tion of 80 mg ml−1 (Fig. 3, right, Table 5). The exceptional
quality of obtained dataset is indicated by the final difference
electron density maps, where the largest peaks of residual
density lie between bonded atoms and represent the bonding
electrons, which are not accounted for by classical spherical
atom refinement models. Sullivan obtained single crystals of
Table 3 Properties of solvents tested for the thermal recrystallization of pABA
Solvent Solubility of pABA at 20 °C Melting point Boiling point Mass (in mg) of pABA for 0.1 ml solvent
2-Propanol 48 g l−1 (ref. 17) −88 °C 82 °C 4.8
Ethyl acetate 68 g l−1 (ref. 17) −83 °C 77 °C 6.8
Acetonitrile 47 g l−1 (ref. 17) −45 °C 82 °C 4.7
Table 4 Chosen amounts of pABA and thermal recrystallization cycle
Solvent
Vial 1
(mg)
Vial 2
(mg)
Vial 3
(mg)
Vial 4
(mg)
Max. temp.
(°C)
Heating rate
(°C min−1)
Lowest temp.
(°C)
Cooling rate
(°C min−1)
2-Propanol 4.5 5 5.5 6 77 1 −15 0.5
Ethyl acetate 6.5 7 7.5 8 72 1 −15 0.5
Acetonitrile 4.5 5 5.5 6 77 1 −15 0.5
Fig. 1 Crystals of CBZ grown from 2-propanol in the shape of needles
and prisms. The picture shows the vial together with the paddle.
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the α-form by isothermal evaporation of saturated solutions
of 2-propanol, ethanol, methanol, ethyl acetate, acetonitrile,
nitromethane and 1 : 1 methanol : toluene at room tempera-
ture and the β-form by isothermal evaporation of saturated
Fig. 2 Crystals of CBZ grown from THF at a concentration of 50 mg ml−1 (left), of 55 mg ml−1 (middle) and of 60 mg ml−1 (right).
Fig. 3 Left: ORTEP representation of the P-monoclinic form of CBZ at 50% probability; right: residual electron density map for the pABA
structure.
Table 5 Crystallographic data of the measured single crystals of CBZ and pABA
Compound CBZ CBZ·1/6ĲH2O) pABA
Grown froma 2-Propanol at a concentration of 15
g l−1
2-Propanol at a concentration of 15
g l−1
Ethyl acetate at a concentration of 80
g l−1
Space group P21/n R3¯ P21/n
Form P-Monoclinic form III12 b α-form39
a [Å] 7.49441Ĳ10) 35.2832(9) 18.5413(3)
b [Å] 11.06430Ĳ14) 35.2832(9) 3.77083(7)
c [Å] 13.80360Ĳ15) 5.20165Ĳ13) 18.5858(3)
α [°] 90 90 90
β [°] 92.9142Ĳ11) 90 93.6727Ĳ17)
γ [°] 90 120 90
Volume [Å3] 1143.12(2) 5608.0(3) 1296.78(4)
Crystal size [mm3] 0.37 × 0.33 × 0.17 0.17 × 0.05 × 0.05 0.34 × 0.09 × 0.07
X-ray wavelength [Å] 0.71073 1.54184 0.71073
Independent reflections 5891 [RĲint) = 0.0244] 2482 [RĲint) = 0.0086] 4512 [RĲint) = 0.0201]
Reflections observed [I >
2σ(I)]
4768 2277 3791
Completeness to resolution 99.9% to 0.60 Å 99.9% to 0.84 Å 99.9% to 0.70 Å
Final R indices [I > 2σ(I)] R1 = 0.0426, wR2 = 0.1200 R1 = 0.0474, wR2 = 0.1566 R1 = 0.0505, wR2 = 0.1313
Largest diff. peak and hole [e
Å−3]
0.459 and −0.219 0.635 and −0.233 0.368 and −0.190
a Used volume: 0.1 ml. b See text in chapter 3.1.
CrystEngComm Paper
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 2
8 
N
ov
em
be
r 2
01
6.
 D
ow
nl
oa
de
d 
on
 0
4/
01
/2
01
7 
09
:4
3:
07
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n-
N
on
Co
m
m
er
ci
al
 3
.0
 U
np
or
te
d 
Li
ce
nc
e.
View Article Online
146 | CrystEngComm, 2017, 19, 142–147 This journal is © The Royal Society of Chemistry 2017
solutions of water.39 They had to wait up to 2 weeks for the
completion of the experiments. Extensive concentration of
the saturated solution at room temperature was obviously es-
sential for crystal growth at least in the case of 2-propanol, as
we could not form any crystals from 2-propanol with our
thermal recrystallization method.
4. Conclusion
This study was done in order to evaluate the growth of
single crystals of small molecules from minute volumes of
only 0.1 ml by thermal recrystallization. For this method,
it is obviously necessary that the desired molecule must
change its solubility with temperature in a steady way and
by a significant amount,40 additionally the molecule must
be stable over the chosen temperature range. Since some
molecules only slightly change their solubility as a func-
tion of temperature, it is extremely helpful to know exactly
the solubility in the chosen solvents at the desired tem-
perature (normally around 25 °C), either from the litera-
ture or from own experimentation. In order to further
minimize the needed amount of material, one could start
with one single initial experiment per solvent at an con-
centration of 150% of the saturated solution. Within only
six hours using the CrystalBreeder, we were able to grow
excellent quality single crystals of carbamazepine and
p-aminobenzoic acid from as little as 1.5 mg of material.
However, it is clear that this method is not suitable for
all molecules, as shown in the case of the vitamin B12.
Additionally, by comparing our results of pABA with the
work of Sullivan,39 it is clear that cooling a slightly super-
saturated solution will not yield in all cases crystals, un-
less evaporation further increases the supersaturation.
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